Bausch Health Companies Inc.071734107CA071734107105/19/2026The approval, in an advisory vote, of the compensation of our Named Executive Officers.SECTION 14A SAY-ON-PAY VOTES5235000.0000000FOR5235000.000000FOR2Henry Schein, Inc.806407102US806407102505/21/2026Proposal to approve, by non-binding vote, the 2025 compensation paid to the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTES15263662.0000000FOR15263662.000000FORCoherus Oncology, Inc.19249H103US19249H103205/29/2026To vote on a non-binding, advisory basis to approve the compensation of the Company's named executive officers (a "Say-on-Pay" vote).SECTION 14A SAY-ON-PAY VOTES3036076.0000000FOR3036076.000000FORNorwegian Cruise Line Holdings Ltd.G66721104BMG66721104606/11/2026Approval, on a non-binding, advisory basis, of the compensation of our named executive officers ("Say-on-Pay Vote")SECTION 14A SAY-ON-PAY VOTES204369.0000000FOR204369.000000FOR1Norwegian Cruise Line Holdings Ltd.G66721104BMG66721104606/11/2026Approval, on a non-binding, advisory basis, of the frequency of future Say-on-Pay VotesSECTION 14A SAY-ON-PAY VOTES204369.0000000ONE YEAR204369.000000FOR1Vroom, Inc.92918V307US92918V307806/11/2026Approve, on an advisory (non-binding) basis, the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTES0.0000000BridgeBio Pharma, Inc.10806X102US10806X102806/22/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTES13260971.0000000FOR13260971.000000FORBridgeBio Pharma, Inc.10806X102US10806X102806/22/2026To conduct a non-binding advisory vote on the frequency of future non-binding advisory votes to approve the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTES13260971.0000000ONE YEAR13260971.000000FOR